Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray.

Experimental Hematology
Norihiko KawamataH Phillip Koeffler

Abstract

Myeloproliferative disorders (MPD) are clonal hematopoietic diseases that include polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (PMF). Mutations in JAK2 are present in many MPD patients. Additional genomic abnormalities are not fully examined in MPD. We used single-nucleotide polymorphism DNA microarray (SNP-chip) to analyze 43 patients with MPD (10 PV, 17 ET, and 16 PMF) for genomic aberrations. Genomic abnormalities were rare in ET. The region containing either RB (13q14) or NF1 (17q11) was deleted in 4 of the 16 PMF, especially PMF with no JAK2 mutations. All five cases of PV having homozygous JAK2V617F had loss of heterozygosity with normal copy number [uniparental disomy] involving the gene. A subpopulation with 9p uniparental disomy was detected in 11 MPD (3 PV, 1 ET, 7 PMF). Uniparental disomy at 1p was found in one PV and three PMF. A novel mutation of MPL (Y591D), which was involved in this uniparental disomy, was found in 1 PV with JAK2 mutation. The other three cases of PMF with 1p uniparental disomy had point mutations of the MPL gene, either a novel mutation (S204F) or the previously described W515L. Genomic abnormalities, including 9p uniparental disomy/JAK2 point mutations, 1p u...Continue Reading

Citations

Jul 6, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Windy Berkofsky-FesslerJonathan D Licht
Apr 27, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hideki Makishima, Jaroslaw P Maciejewski
Dec 17, 2009·Hematology·Radek C Skoda
Jan 29, 2013·Journal of Hematology & Oncology·Xin HeXiaoying Zhao
Mar 13, 2014·Experimental Hematology·Veena SangkhaeIan Stuart Hitchcock
Dec 10, 2015·Experimental Hematology·Linghua WangJosef T Prchal
Sep 27, 2012·Hematology/oncology Clinics of North America·Anna L Godfrey, Anthony R Green
Sep 27, 2012·Hematology/oncology Clinics of North America·Joannah Score, Nicholas C P Cross
Feb 1, 2012·Seminars in Oncology·Aiko Sato-OtsuboSeishi Ogawa
Jul 25, 2012·Biochimica Et Biophysica Acta·Maria Kleppe, Ross L Levine
Jun 10, 2011·Blood·William VainchenkerOlivier A Bernard
Jan 29, 2010·Blood·Christine O'KeefeJaroslaw P Maciejewski
Aug 16, 2016·Blood Cells, Molecules & Diseases·Armin RashidiStephen T Oh
Jan 1, 2015·Microarrays·Jinming Song, Haipeng Shao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.